Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Challenges and Advances in Tuberculosis and Mycobacterial Lung Diseases
| Challenges and Advances in Tuberculosis and Mycobacterial Lung Diseases |
| Autore | Szturmowicz Monika |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 electronic resource (140 p.) |
| Soggetto topico | Public health & preventive medicine |
| Soggetto non controllato |
Gordonia bronchialis
microbiological diagnostics respiratory infection Mycobacterium tuberculosis drug resistance XDR-tuberculosis household TB transmission tuberculous pericarditis extrapulmonary tuberculosis pericarditis constrictive pericarditis tuberculosis abscess scrofula head and neck epiglottis larynx airway mycobacteria surgical drainage FluoroType MTBDR molecular isoniazid rifampin bacillus Calmette-Guerin bladder cancer immunotherapy BCGosis BCG pulmonary infection severe respiratory insufficiency nontuberculous mycobacterium lung cancer surgery nontuberculous mycobacteria cystic fibrosis chest computed tomography Beijing-TB Beijing-like genotype Mycobacterium chimaera nontuberculous mycobacterial disease silicosis extracorporeal membrane oxygenation COVID-19 pandemic spoligotyping Poland human immunodeficiency virus acquired immunodeficiency syndrome chest imaging rapidly growing mycobacteria antimicrobial resistance broth microdilution minimal inhibitory concentration (MIC) |
| ISBN | 3-0365-5492-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910637783103321 |
Szturmowicz Monika
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Tuberculosis Drug Discovery and Development 2019
| Tuberculosis Drug Discovery and Development 2019 |
| Autore | Riccardi Giovanna |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 electronic resource (296 p.) |
| Soggetto topico |
Research & information: general
Biology, life sciences |
| Soggetto non controllato |
mycobacteria
tuberculosis multi-drug resistance drug discovery promiscuous targets Mycobacterium tuberculosis rifampin isoniazid mechanisms of resistance mutations granulomas caseum cell envelope dormancy delpazolid macozinone DprE1 inhibitor clinical studies discovery mode of action drug resistance toxicity target energy metabolism electron transport chain oxidative phosphorylation bedaquiline Q203 MID3 pharmacokinetics pharmacodynamics drug-drug interactions in vitro in vivo drug development tuberculosis treatment biomarkers drug combination clinical trial BCG tuberculosis vaccines TBVI EDCTP IAVI CTVD host-directed therapy anti-virulence compounds TB post-treatment sequelae surgery pulmonary rehabilitation Carlo Forlanini artificial pneumothorax structure-based drug design target-based drug design PknB PknG DNA gyrase antibiotic mycobacterium genomics transcriptomics proteomics metabolomics lipidomics target identification mechanism of action antimicrobial drug resistance (AMR) target-based screening phenotypic screening antituberculosis agents antimycobacterial anti-TB drug pipeline privileged targets lead generation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557627203321 |
|
Riccardi Giovanna
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||